Any feedback?
Please rate this page
(organism.php)
(0/150)

BRENDA support

Information on Organism Sporothrix schenckii

TaxTree of Organism Sporothrix schenckii
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
PATHWAY
BRENDA Link
KEGG Link
MetaCyc Link
(S)-lactate fermentation to propanoate, acetate and hydrogen
-
-
PWY-8086
1,3-propanediol biosynthesis (engineered)
-
-
PWY-7385
1,5-anhydrofructose degradation
-
-
PWY-6992
1-butanol autotrophic biosynthesis (engineered)
-
-
PWY-6886
2-arachidonoylglycerol biosynthesis
-
-
PWY-8052
24-epi-campesterol, fucosterol, and clionasterol biosynthesis (diatoms)
-
-
PWY-8238
acetone degradation I (to methylglyoxal)
-
-
PWY-5451
acetone degradation III (to propane-1,2-diol)
-
-
PWY-7466
adenine and adenosine salvage III
-
-
PWY-6609
adenine and adenosine salvage V
-
-
PWY-6611
adenosine nucleotides degradation II
-
-
SALVADEHYPOX-PWY
alanine metabolism
-
-
Alanine, aspartate and glutamate metabolism
-
-
alpha-linolenate metabolites biosynthesis
-
-
PWY-8398
alpha-Linolenic acid metabolism
-
-
Amaryllidacea alkaloids biosynthesis
-
-
PWY-7826
Amino sugar and nucleotide sugar metabolism
-
-
Aminobenzoate degradation
-
-
ammonia oxidation II (anaerobic)
-
-
P303-PWY
anaerobic energy metabolism (invertebrates, cytosol)
-
-
PWY-7383
anandamide biosynthesis I
-
-
PWY-8051
anandamide biosynthesis II
-
-
PWY-8053
arachidonate metabolites biosynthesis
-
-
PWY-8397
Arachidonic acid metabolism
-
-
arachidonic acid metabolism
-
-
Arginine and proline metabolism
-
-
Arginine biosynthesis
-
-
aspirin triggered resolvin D biosynthesis
-
-
PWY66-395
aspirin triggered resolvin E biosynthesis
-
-
PWY66-394
Atrazine degradation
-
-
Benzoate degradation
-
-
Bifidobacterium shunt
-
-
P124-PWY
Biosynthesis of 12-, 14- and 16-membered macrolides
-
-
Biosynthesis of secondary metabolites
-
-
bupropion degradation
-
-
PWY66-241
C4 and CAM-carbon fixation
-
-
C4 photosynthetic carbon assimilation cycle, NAD-ME type
-
-
PWY-7115
Caffeine metabolism
-
-
Calvin-Benson-Bassham cycle
-
-
CALVIN-PWY
Carbon fixation in photosynthetic organisms
-
-
Carbon fixation pathways in prokaryotes
-
-
chitin biosynthesis
-
-
PWY-6981
chitin degradation I (archaea)
-
-
PWY-6855
chitin degradation II (Vibrio)
-
-
PWY-6902
chitin degradation III (Serratia)
-
-
PWY-7822
cholesterol biosynthesis
-
-
cholesterol biosynthesis (algae, late side-chain reductase)
-
-
PWY-8191
cholesterol biosynthesis (diatoms)
-
-
PWY-8239
cholesterol biosynthesis (plants, early side-chain reductase)
-
-
PWY18C3-1
cholesterol biosynthesis II (via 24,25-dihydrolanosterol)
-
-
PWY66-3
Citrate cycle (TCA cycle)
-
-
citric acid cycle
-
-
CMP-legionaminate biosynthesis I
-
-
PWY-6749
cyanuric acid degradation I
-
-
PWY-8025
cyanuric acid degradation II
-
-
PWY-5169
Cysteine and methionine metabolism
-
-
cysteine metabolism
-
-
cytosolic NADPH production (yeast)
-
-
PWY-7268
d-mannose degradation
-
-
degradation of sugar alcohols
-
-
denitrification
-
-
di-homo-gamma-linolenate metabolites biosynthesis
-
-
PWY-8396
docosahexaenoate metabolites biosynthesis
-
-
PWY-8400
dolichyl-diphosphooligosaccharide biosynthesis
-
-
Drug metabolism - cytochrome P450
-
-
Drug metabolism - other enzymes
-
-
dZTP biosynthesis
-
-
PWY-8289
Entner-Doudoroff pathway I
-
-
PWY-8004
Entner-Doudoroff pathway II (non-phosphorylative)
-
-
NPGLUCAT-PWY
Entner-Doudoroff pathway III (semi-phosphorylative)
-
-
PWY-2221
ergosterol biosynthesis II
-
-
PWY-7154
erythromycin D biosynthesis
-
-
PWY-7106
ethanol degradation IV
-
-
PWY66-162
ethene biosynthesis III (microbes)
-
-
PWY-6854
ethene biosynthesis V (engineered)
-
-
PWY-7124
Ether lipid metabolism
-
-
Fatty acid degradation
-
-
formaldehyde assimilation I (serine pathway)
-
-
PWY-1622
formaldehyde assimilation II (assimilatory RuMP Cycle)
-
-
PWY-1861
formaldehyde assimilation III (dihydroxyacetone cycle)
-
-
P185-PWY
formaldehyde oxidation
-
-
formaldehyde oxidation I
-
-
RUMP-PWY
formaldehyde oxidation II (glutathione-dependent)
-
-
PWY-1801
fructan degradation
-
-
PWY-862
Fructose and mannose metabolism
-
-
Galactose metabolism
-
-
gluconeogenesis I
-
-
GLUCONEO-PWY
gluconeogenesis II (Methanobacterium thermoautotrophicum)
-
-
PWY-6142
gluconeogenesis III
-
-
PWY66-399
Glutathione metabolism
-
-
glycerol degradation to butanol
-
-
PWY-7003
Glycerolipid metabolism
-
-
Glycerophospholipid metabolism
-
-
Glycine, serine and threonine metabolism
-
-
glycogen metabolism
-
-
glycolysis
-
-
Glycolysis / Gluconeogenesis
-
-
glycolysis I (from glucose 6-phosphate)
-
-
GLYCOLYSIS
glycolysis II (from fructose 6-phosphate)
-
-
PWY-5484
glycolysis III (from glucose)
-
-
ANAGLYCOLYSIS-PWY
glycolysis IV
-
-
PWY-1042
glycolysis V (Pyrococcus)
-
-
P341-PWY
Glycosaminoglycan degradation
-
-
Glycosphingolipid biosynthesis - ganglio series
-
-
Glyoxylate and dicarboxylate metabolism
-
-
glyoxylate cycle
-
-
GLYOXYLATE-BYPASS
gossypol biosynthesis
-
-
PWY-5773
heterolactic fermentation
-
-
P122-PWY
homocysteine and cysteine interconversion
-
-
PWY-801
hydrogen sulfide biosynthesis II (mammalian)
-
-
PWY66-426
icosapentaenoate metabolites biosynthesis
-
-
PWY-8399
incomplete reductive TCA cycle
-
-
P42-PWY
Inositol phosphate metabolism
-
-
isoprene biosynthesis II (engineered)
-
-
PWY-7391
Isoquinoline alkaloid biosynthesis
-
-
justicidin B biosynthesis
-
-
PWY-6824
L-cysteine biosynthesis III (from L-homocysteine)
-
-
HOMOCYSDEGR-PWY
L-histidine degradation V
-
-
PWY-5031
L-lactaldehyde degradation
-
-
lactate fermentation
-
-
linoleate metabolites biosynthesis
-
-
PWY-8395
Linoleic acid metabolism
-
-
lipid metabolism
-
-
macrolide antibiotic biosynthesis
-
-
malate/L-aspartate shuttle pathway
-
-
MALATE-ASPARTATE-SHUTTLE-PWY
maresin biosynthesis
-
-
PWY-8356
matairesinol biosynthesis
-
-
PWY-5466
melatonin degradation I
-
-
PWY-6398
Metabolic pathways
-
-
metabolism of disaccharids
-
-
Metabolism of xenobiotics by cytochrome P450
-
-
Methane metabolism
-
-
methanol oxidation to formaldehyde IV
-
-
PWY-5506
methylaspartate cycle
mevalonate metabolism
-
-
mevalonate pathway I (eukaryotes and bacteria)
-
-
PWY-922
mevalonate pathway II (haloarchaea)
-
-
PWY-6174
mevalonate pathway III (Thermoplasma)
-
-
PWY-7524
mevalonate pathway IV (archaea)
-
-
PWY-8125
Microbial metabolism in diverse environments
-
-
mixed acid fermentation
-
-
FERMENTATION-PWY
N-Glycan biosynthesis
-
-
NAD metabolism
-
-
NADPH to cytochrome c oxidase via plastocyanin
-
-
PWY-8271
Nicotinate and nicotinamide metabolism
-
-
nicotine degradation IV
-
-
PWY66-201
nicotine degradation V
-
-
PWY66-221
nitrate reduction I (denitrification)
-
-
DENITRIFICATION-PWY
nitrate reduction VII (denitrification)
-
-
PWY-6748
nitric oxide biosynthesis II (mammals)
-
-
PWY-4983
nitrifier denitrification
-
-
PWY-7084
nitrite-dependent anaerobic methane oxidation
-
-
PWY-6523
Nitrogen metabolism
-
-
nitrogen remobilization from senescing leaves
-
-
PWY-6549
nocardicin A biosynthesis
-
-
PWY-7797
non-pathway related
-
-
o-diquinones biosynthesis
-
-
PWY-6752
Other glycan degradation
-
-
Pantothenate and CoA biosynthesis
-
-
partial TCA cycle (obligate autotrophs)
-
-
PWY-5913
Pentose phosphate pathway
-
-
pentose phosphate pathway
-
-
pentose phosphate pathway (non-oxidative branch) II
-
-
PWY-8178
pentose phosphate pathway (oxidative branch) I
-
-
OXIDATIVEPENT-PWY
peptido-conjugates in tissue regeneration biosynthesis
-
-
PWY-8355
phosphate acquisition
-
-
PWY-6348
phosphatidylcholine acyl editing
-
-
PWY-6803
phospholipases
-
-
LIPASYN-PWY
phospholipid remodeling (phosphatidate, yeast)
-
-
PWY-7417
phospholipid remodeling (phosphatidylcholine, yeast)
-
-
PWY-7416
phospholipid remodeling (phosphatidylethanolamine, yeast)
-
-
PWY-7409
Photosynthesis
-
-
photosynthesis
-
-
photosynthesis light reactions
-
-
PWY-101
photosynthetic 3-hydroxybutanoate biosynthesis (engineered)
-
-
PWY-7218
phytosterol biosynthesis (plants)
-
-
PWY-2541
plasmalogen biosynthesis I (aerobic)
-
-
PWY-7782
plasmalogen degradation
-
-
PWY-7783
Propanoate metabolism
-
-
protectin biosynthesis
-
-
PWY-8357
protein N-glycosylation (Haloferax volcanii)
-
-
PWY-7661
protein N-glycosylation initial phase (eukaryotic)
-
-
MANNOSYL-CHITO-DOLICHOL-BIOSYNTHESIS
protein N-glycosylation processing phase (endoplasmic reticulum, yeast)
-
-
PWY-7918
protein N-glycosylation processing phase (plants and animals)
-
-
PWY-7919
protein O-mannosylation I (yeast)
-
-
PWY-7921
protein O-mannosylation II (mammals, core M1 and core M2)
-
-
PWY-7922
protein O-mannosylation III (mammals, core M3)
-
-
PWY-7979
protein S-nitrosylation and denitrosylation
-
-
PWY-7798
purine deoxyribonucleosides degradation I
-
-
PWY-7179
purine deoxyribonucleosides degradation II
-
-
PWY-7179-1
Purine metabolism
-
-
purine metabolism
-
-
purine ribonucleosides degradation
-
-
PWY0-1296
pyrimidine deoxyribonucleotides biosynthesis from CTP
-
-
PWY-7210
pyrimidine deoxyribonucleotides de novo biosynthesis I
-
-
PWY-7184
pyrimidine deoxyribonucleotides de novo biosynthesis II
-
-
PWY-7187
pyrimidine deoxyribonucleotides de novo biosynthesis III
-
-
PWY-6545
pyrimidine deoxyribonucleotides dephosphorylation
-
-
PWY-7206
Pyrimidine metabolism
-
-
pyruvate fermentation to (S)-lactate
-
-
PWY-5481
pyruvate fermentation to propanoate I
-
-
P108-PWY
Pyruvate metabolism
-
-
reactive oxygen species degradation
-
-
DETOX1-PWY-1
reductive TCA cycle I
-
-
P23-PWY
reductive TCA cycle II
-
-
PWY-5392
resolvin D biosynthesis
-
-
PWY66-397
retinol biosynthesis
-
-
PWY-6857
Retinol metabolism
-
-
Riboflavin metabolism
-
-
Rubisco shunt
-
-
PWY-5723
sedoheptulose bisphosphate bypass
-
-
PWY0-1517
sesamin biosynthesis
-
-
PWY-5469
Sphingolipid metabolism
-
-
Starch and sucrose metabolism
-
-
starch degradation
-
-
Steroid biosynthesis
-
-
Steroid hormone biosynthesis
-
-
sucrose biosynthesis I (from photosynthesis)
-
-
SUCSYN-PWY
sucrose degradation V (sucrose alpha-glucosidase)
-
-
PWY66-373
superoxide radicals degradation
-
-
DETOX1-PWY
superpathway of glucose and xylose degradation
-
-
PWY-6901
superpathway of glycolysis and the Entner-Doudoroff pathway
-
-
GLYCOLYSIS-E-D
superpathway of glyoxylate cycle and fatty acid degradation
-
-
PWY-561
superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis (E. coli)
-
-
PWY0-166
taurine biosynthesis III
-
-
PWY-8359
TCA cycle I (prokaryotic)
-
-
TCA
TCA cycle II (plants and fungi)
-
-
PWY-5690
TCA cycle III (animals)
-
-
PWY66-398
TCA cycle IV (2-oxoglutarate decarboxylase)
-
-
P105-PWY
TCA cycle V (2-oxoglutarate synthase)
-
-
PWY-6969
TCA cycle VI (Helicobacter)
-
-
REDCITCYC
TCA cycle VII (acetate-producers)
-
-
PWY-7254
TCA cycle VIII (Chlamydia)
-
-
TCA-1
Terpenoid backbone biosynthesis
-
-
Thiamine metabolism
-
-
trehalose degradation II (cytosolic)
-
-
PWY0-1182
trehalose degradation VI (periplasmic)
-
-
PWY0-1466
triacylglycerol degradation
-
-
LIPAS-PWY
Tryptophan metabolism
-
-
tunicamycin biosynthesis
-
-
PWY-7821
Tyrosine metabolism
-
-
UDP-GlcNAc biosynthesis
-
-
UDP-N-acetyl-D-galactosamine biosynthesis III
-
-
PWY-8013
UDP-N-acetyl-D-glucosamine biosynthesis I
-
-
UDPNAGSYN-PWY
UDP-N-acetyl-D-glucosamine biosynthesis II
-
-
UDPNACETYLGALSYN-PWY
urea cycle
-
-
urea degradation II
-
-
PWY-5704
UTP and CTP dephosphorylation I
-
-
PWY-7185
vanillin biosynthesis I
-
-
PWY-5665
Various types of N-glycan biosynthesis
-
-
vitamin B1 metabolism
-
-
xyloglucan degradation II (exoglucanase)
-
-
PWY-6807
zymosterol biosynthesis
-
-
PWY-6074
ORGANISM
COMMENTARY hide
LITERATURE
UNIPROT
SEQUENCE DB
SOURCE
SOURCE TISSUE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
SOURCE
additional information
conditions to obtain the yeast (pH 7.0, 37°C) or the mycelial (pH 4.5, 28°C) morphotypes. Congo Red (CR) affects the growth, morphology, and activity of glucosamine-6-phosphate synthase in human pathogenic fungus Sporothrix schenckii. Under conditions of yeast development, 0.015 mM CR abolishes conidia germination, but when yeast cells are first obtained in the absence of the dye and then post-incubated in its presence, yeasts rapidly differentiate into mycelial cells. On the other hand, under conditions of mycelium development, 0.150 mM CR do not affect conidia germination, but filamentous cells undergo structural changes characterized by a distorted cell wall contour, the loss of polarity and the formation of red-pigmented, hyphal globose structures. Under these conditions, CR also induces a significant and transient increase in the activity of GlcN-6-P synthase, an essential enzyme in cell wall biogenesis
Manually annotated by BRENDA team
LOCALIZATION
ORGANISM
UNIPROT
COMMENTARY hide
GeneOntology No.
LITERATURE
SOURCE
-
50% of total enzyme activity in a mixed membrane fraction
Manually annotated by BRENDA team
-
38% of total enzyme activity
-
Manually annotated by BRENDA team
LINKS TO OTHER DATABASES (specific for Sporothrix schenckii)